Generex Biotechnology Corp.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1983-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.generex.com
Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
- Conditions
- Type 2 Diabetes MellitusType 1 Diabetes Mellitus
- First Posted Date
- 2009-07-29
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Generex Biotechnology Corp.
- Registration Number
- NCT00948493
Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin
Phase 3
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Generex Oral-lyn™Drug: Regular human insulin
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Generex Biotechnology Corp.
- Target Recruit Count
- 500
- Registration Number
- NCT00668850
- Locations
- 🇨🇦
The Bailey Clinic at Red Deer, #108 3947 50A Avenue, Alberta, Canada
🇪🇨Instituto de Endocrinologia IEMYR, Avenida La Coruña Nº 6337 y San Ignacio, Quito, Ecuador
🇵🇱OSTEOMED Medical Center at Warszawa, ul. Bialobrzeska 40A, Poland
© Copyright 2025. All Rights Reserved by MedPath